A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA
Clinical trial NCT02258542 · COMPLETED
Trial details
- NCT number
- NCT02258542
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-19
- Primary completion
- 2017-10-18
- Enrollment
- 2133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.